Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 46-1477964 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The corporation is organized and shall operate for the purpose of conducting scientific research for the treatment of malignancies and diseases including covid-19, utilizing stem cell based approaches in order to improve the quality of life and the making of distributions to organizations that qualify as exempt organizations under section 501(c)(3), 2055(a) and 170 (c)(2) of the internal revenue code.
Principal Officer
Duncan B Ross
Total Revenue
$196K
FY2024
Total Expenses
$276K
FY2024
Net Assets
-$539K
Program Ratio
78.5%
expenses on programs
Employees
2
Volunteers
—
Board Members
4
Voting
4
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.